Amoxicillin-Clavulanate Extended-Release Tablets 1000mg/62.5mg from China
XR formulation combining amoxicillin and clavulanate for twice-daily dosing in respiratory infections. This mixed penicillin-based antibiotic in measured tablet doses for retail qualifies under HTS 3004.10.50.49 'other combination antibiotics'.
Duty Rate — China → United States
0%
Rate breakdown
9903.05.860%Universal product exemption (U.S. note 52(b))
Import Tips
• Include dissolution profile testing for extended-release verification
• Ensure child-resistant blister packaging for retail compliance
• Monitor for DEA scheduling if combined with controlled substances